0001104659-16-122085 Sample Contracts

CELLDEX THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement

Celldex Therapeutics, Inc. • May 19th, 2016 • In vitro & in vivo diagnostic substances • New York

• Company
  Celldex Therapeutics, Inc.
• Filed
  May 19th, 2016
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  New York

Celldex Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: